Evenepoel et al. highlighted the lack of consensus on managing hyperparathyroidism in transplant candidates, reporting that American dialysis centers hold divergent views on whether elevated pre-transplant PTH levels negatively affect graft survival.(26) While many centers consider severe hyperparathyroidism a risk factor for post-transplant complications, others prioritize kidney allocation without specifically factoring PTH levels. The gene discussed is PTH; the disease is hyperparathyroidism.